Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to the Centers for Disease Control and Prevention.

Moderna Inc. said its experimental flu shot showed positive results in a late-stage trial.

Moderna's experimental flu shot shows positive results in a late-stage trial, promising stronger efficacy and protection against various strains.

Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to the Centers for Disease Control and Prevention.

Moderna said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot for the virus in a late-stage trial.

Yet that vaccine panel recommended Thursday that people should receive only thimerosal-free flu vaccinations this fall — something already easy to do since government data shows only a small ...